Code | 06621 | ||||||||||
MA number | EU/1/11/676/001 | ||||||||||
Product Form: | cif fol 1x1,5 ml/60 mg konc. + 1x4,5 ml solv. (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 17.03.2011 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHCP_Jevtana 7 11 2013.pdf |
Safety feature | Yes |
Data update: | 30.12.2020 |